BRUSSELS, April 9 (Reuters) - Pharmaceutical group Fagron said sales growth in the first quarter slowed slightly from the second half of last year, but maintained its full-year outlook.
The company, which makes ingredients for pharmacists to make bespoke medicines, said sales in the first quarter increased by 29.8 percent from last year to 117.8 million euros ($126.92 million).
11:00 113 Houston companies make Inc. 5000 list of fast growers8
10:36 Emma Stone is 2017's highest-paid actress; dethroning Jennifer Lawrence22
19:59 Girl killed, several injured after car intentionally slams into patrons at pizzeria near Paris, police say34
10:31 $393 million winning Mega Millions ticket sold in Illinois: lottery officials29